SRRK
NASDAQ · Biotechnology
Scholar Rock Holding Corp
$48.39
+1.94 (+4.18%)
Performance
1D
—
1W
—
1M
—
3M
+1.13%
6M
+64.76%
1Y
+57.78%
YTD
+13.06%
Open$46.40
Previous Close$46.45
Day High$48.46
Day Low$45.90
52W High$51.63
52W Low$27.07
Volume—
Avg Volume1.26M
Market Cap5.56B
P/E Ratio—
EPS$-3.30
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$45.16
Above
SMA 200
$36.91
Above
RSI (14)
59.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
+47.3% upside
Current
$48.39
$48.39
Target
$71.29
$71.29
$54.07
$71.29 avg
$91.55
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 910.50M | 880.80M | 846.68M |
| Net Income | -11,497,538 | -12,296,426 | -11,692,649 |
| Profit Margin | -1.3% | -1.4% | -1.4% |
| EBITDA | -11,509,292 | -12,212,052 | -11,111,961 |
| Free Cash Flow | -10,999,659 | -14,100,591 | -9,156,076 |
| Rev Growth | +11.0% | +3.4% | +15.4% |
| Debt/Equity | 0.75 | 0.83 | 0.78 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |